Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s...
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®,...
Lantern Pharma Inc., an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (“ML”) platform...